Medpace Holdings, Inc.
MEDP
Rank in Stocks
#1298
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Share Price
$629.83
Market Cap
$17.58B
Change (1 day)
1.64%
Change (1 year)
15.69%
Country
US
Trade Medpace Holdings, Inc. (MEDP)
Category
Healthcare
Number of shares outstanding for Medpace Holdings, Inc. (MEDP)
Number of shares outstanding as of June 2026: 28.31M
According to Medpace Holdings, Inc. latest financial reports and stock price the company's current number of shares outstanding is 28.31M. At the end of December 2024 the company had 30.96M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Medpace Holdings, Inc. (MEDP) from 2013 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 28.31M | -1.87% |
| 2025 | 28.85M | -6.82% |
| 2024 | 30.96M | 0.76% |
| 2023 | 30.72M | -5.14% |
| 2022 | 32.39M | -9.69% |
| 2021 | 35.86M | 0.64% |
| 2020 | 35.64M | -0.69% |
| 2019 | 35.88M | 0.94% |
| 2018 | 35.55M | -8.98% |
| 2017 | 39.06M | 9.43% |
| 2016 | 35.69M | -9.94% |
| 2015 | 39.63M | 34.65% |
| 2014 | 29.43M | -23.24% |
| 2013 | 38.35M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 371.00M | 1,210.58% |
US
|
|
| 705.30M | 2,391.52% |
US
|
|
| 143.28M | 406.14% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 896.18% |
US
|
